[Federal Register Volume 70, Number 203 (Friday, October 21, 2005)]
[Notices]
[Pages 61261-61262]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-21068]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patents and Patent Applications Concerning Bacterial 
Superantigen Vaccines

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made

[[Page 61262]]

of the availability for licensing of U.S. Patent No. 6,399,332 entitled 
``Bacterial Superantigen Vaccines,'' issued June 4, 2002; U.S. Patent 
No. 6,713,284 entitled ``Bacterial Superantigen Vaccines,'' issued 
March 30, 2004; U.S. Patent Application No. 10/757,687 entitled 
``Bacterial Superantigen Vaccines,'' filed January 29, 2004, which is a 
divisional of U.S. Patent No. 6,713,284; and U.S. Patent Application 
No. 10/002,784 entitled ``Bacterial Superantigen Vaccines,'' filed 
November 26, 2001, which is a continuation in part of U.S. Patent No. 
6,713,284. Foreign rights are also available (PCT/US98/16766 and PCT/
US01/46540). The United States Government, as represented by the 
Secretary of the Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Material Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The present invention relates to genetically 
attenuated superantigen toxin vaccines altered such that superantigen 
attributes are absent, however the superantigen is effectively 
recognized and an appropriate immune response is produced. The 
attenuated superantigen toxins are shown to protect animals against 
challenge with wild type toxin. Methods of producing and using the 
altered superantigen toxins are described.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 05-21068 Filed 10-20-05; 8:45 am]
BILLING CODE 3710-08-M